BNP Paribas Financial Markets’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,267,838
Closed -$225M 4450
2020
Q1
$225M Buy
1,267,838
+369,949
+41% +$69.7M 0.46% 33
2019
Q4
$172M Buy
897,889
+554,726
+162% +$100M 0.31% 59
2019
Q3
$57.8M Sell
343,163
-37,784
-10% -$6.16M 0.1% 198
2019
Q2
$63.8M Sell
380,947
-97,893
-20% -$13.6M 0.13% 172
2019
Q1
$70.1M Sell
478,840
-317
-0.1% -$46K 0.15% 145
2018
Q4
$64M Sell
479,157
-77,239
-14% -$12.7M 0.15% 149
2018
Q3
$106M Buy
556,396
+48,324
+10% +$8.88M 0.16% 128
2018
Q2
$84.7M Buy
508,072
+298,992
+143% +$48M 0.14% 145
2018
Q1
$35.2M Sell
209,080
-47,799
-19% -$8.02M 0.07% 280
2017
Q4
$42M Sell
256,879
-111,497
-30% -$20M 0.07% 242
2017
Q3
$75.5M Buy
368,376
+26,212
+8% +$6.1M 0.18% 105
2017
Q2
$83.2M Sell
342,164
-84,225
-20% -$19.8M 0.25% 85
2017
Q1
$102M Buy
426,389
+309,995
+266% +$72.2M 0.27% 77
2016
Q4
$24.4M Sell
116,394
-38,635
-25% -$8M 0.11% 158
2016
Q3
$35.7M Buy
155,029
+26,245
+20% +$6.41M 0.15% 113
2016
Q2
$29.8M Sell
128,784
-180,476
-58% -$41.6M 0.13% 107
2016
Q1
$82.9M Sell
309,260
-96,145
-24% -$27.5M 0.35% 54
2015
Q4
$127M Buy
405,405
+7,971
+2% +$2.37M 0.31% 63
2015
Q3
$108M Buy
+397,434
New +$122M 0.27% 58
2015
Q2
Sell
-129,695
Closed -$55.7M 3668
2015
Q1
$55.7M Buy
129,695
+13,782
+12% +$3.93M 0.15% 88
2014
Q4
$29.8M Sell
115,913
-7,073
-6% -$1.77M 0.11% 163
2014
Q3
$29.7M Buy
122,986
+637
+0.5% +$143K 0.03% 248
2014
Q2
$27.3M Buy
122,349
+55,036
+82% +$11.4M 0.03% 218
2014
Q1
$13.8M Sell
67,313
-27,323
-29% -$5.41M 0.01% 383
2013
Q4
$15.9M Sell
94,636
-32,462
-26% -$5.07M 0.01% 349
2013
Q3
$18.3M Buy
127,098
+114,897
+942% +$15.3M 0.01% 343
2013
Q2
$1.54M Buy
+12,201
New +$1.38M ﹤0.01% 826

Other funds holding AGN

BNP Paribas Financial Markets's AGN Position: Q2 2020 in Review

BNP Paribas Financial Markets sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,267,838 shares — an estimated $225M sold.

BNP Paribas Financial Markets first reported a position in AGN in Q2 2013 and held it in 27 quarters. The position peaked at $225M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • BNP Paribas Financial Markets reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 1,267,838 Allergan plc shares in Q2 2020, an estimated $225M.
  • BNP Paribas Financial Markets first reported a position in Allergan plc in Q2 2013 and held it in 27 quarters.
  • BNP Paribas Financial Markets's Allergan plc position peaked at $225M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2020, filed 6 Aug 2020.